Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300068723Phase 4Not yet recruiting
Phase 4, randomised trial of ascorbic acid in hip osteoarthritis (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Visual analogue scale (VAS) pain score, Cumulative use of morphine and 3 more. Planned start Feb 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300068723.